NCT02011737

Naftopidil 75mg for Improving Clearance of Urinary Stones

The Effectiveness and Safety of Naftopidil 75mg for Improving Clearance of Ureteral and Renal Stones After Shockwave Lithotripsy: Prospective Randomized Controlled Study

• Status: Unknown
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 130 (estimated)
• Sponsor: Samsung Medical Center · Academic / Other
• Sex: All
• Age: 15 Years – 80 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to evaluate Efficacy and Safety of oral intake of Naftopidil 75mg once daily for the improving clearance of ureteral or renal stones.

Detailed description

Prospective, Single-center, Double blind, Randomized controlled trial Treatment \- Oral Naftopidil 75 mg once daily are given to the patients who are scheduled for shockwave lithotripsy (ESWL) because of ureteral or renal stones. Follow up Assessments including X-ray(KUB), visual analogue pain scale, are done 2, 4, and 6 weeks after the ESWL.

Conditions

• Kidney Calculi
• Ureter Calculi

Interventions

Type	Name	Description
DRUG	naftopidil 75mg

Timeline

• Start date: 2014-02-01
• Primary completion: 2015-02-01
• Completion: 2015-04-01
• First posted: 2013-12-13
• Last updated: 2013-12-13

Locations

1 site across 1 country: South Korea